MANAGING INTRAOPERATIVE FLOPPY IRIS SYNDROME WITH CANABRAVA PUPIL DILATOR

Authors

  • Naum Trpenoski PZU Promedika Medikal Centar, Republic of North Macedonia
  • Aleksandar Veselinovic Eye Disease Clinic – KC NIS, Republic of Serbia
  • Marija Cvetanovic Eye Disease Clinic – KC NIS, Republic of Serbia
  • Marija Grekovska Mitrova PZU Promedika Medikal Centar, Republic of North Macedonia

Keywords:

Cataract, Tamsulosin®, Canabrava mechanical pupillary dilator, Intraoperative floppy iris syndrome (IFIS)

Abstract

Intra-operative floppy iris syndrome (IFIS) also known as small pupil syndrome is a clinical entity that was first described by Chang and Campbell in 2005. IFIS is associated with those patients currently undergoing preoperative evaluations for cataracts that are on systemic therapy from the group of a1-adrenergic blockers, with a strong emphasis on Tamsulosin, the first drug of choice for treating benign prostatic hyperplasia(BPH).

IFIS is characterized by a symptom triad of intraoperative signs during phacoemulsification surgery: flaccid stroma of the iris, prolapse of the iris through intraoperative incisions and progressive miosis. In these patients without adequate dilatation of the pupil, the syndrome itself leads to reduced visualization of the operative field and possible operative complications, the most common of which are posterior capsule rupture, iris transillumination characterized by bilateral acute iris dispersion, and pupillary sphincter tear.

The goal of this study was to determine the need for Canabrava mechanical pupillary dilator during cataract surgery with phacoemulsification in patients at high risk for IFIS and who are on systemic therapy with Tamsulosin®, i.e. α1-adrenergic blockers due to benign hyperplasia of the prostate.

During the study 40 patients were included and two groups were formed. The first control group consisted of 20 patients in whom Canabrava pupillary dilator was not used intraoperatively during phacoemulsification, and the second group consisted of the other 20 patients in whom Canabrava pupillary dilator was used intraoperatively in cataract surgery with phacoemulsification. All patients were monitored for: preoperative and postoperative best corrected visual acuity (BCVA), preoperative and intraoperative iris diameter, and the occurrence of intraoperative and postoperative complications.

This study demonstrated that the Canabrava dilator, that allows the expansion of myotic pupils as well as the prevention of intraoperative and postoperative complications, is of great importance in patients with IFIS, ie during intraoperative use of Canabrava mechanical pupillary dilator we noticed a significant difference only in intraoperative and postoperative complications in patients who were included in the control and study groups.We achieved safe phacoemulsification surgery despite the fact that the patients were on systemic therapy from the group of α1-adrenergic blockers, namely Tamsulosin®. 

References

Alpa, S. P., Kousnik, T., &Akkara, J.D. (2020). Pupil expansion devices and mechanical Stretching od the pupil,

Chang, D.F., Braga-Mele R., Mamalis N., Masket S., Miller K.M., Nichamin L.D., Packard R.B. & Packer M. (2008). Clinical experience with intraoperative floppy-iris syndrome. Results of the 2008 ASCRS member survey, J Cataract Refract Surg., 34(7):1201-9. doi: 10.1016/j.jcrs.2008.04.014

Christou, C.D., Tsinopoulos, I., Ziakas, N., & Tzamalis, A. (2020). Intraoperative Floppy Iris Syndrome: Updated Perspective, Clinical Ophthalmology, 14 463–471

Campbell., R.J. El-Defrawy., S. R., Gill., S. S., Whitehead., M., de L.P. Campbell., E., Hooper., P.L., Chaim M. Bell., Martin W. ten Hove., (2019). Evolution in the Risk of Cataract surgical complications among patients exposed to tamsulosin – Volume 126 - Issue 4 - P490-496,

Canabrava, S., & Rezende, P. H. (2018). Efficacy of the Canabrava Ring (pupil expansion device) in cataract surgery for eyes with small pupils,. Arq Bras Oftalmol, 2018

Enright, J.M., Karacal, H., Tsai, L.M. (2017). Floppy iris syndrome and cataract surgery, January 2017 - Volume 28 - Issue 1 - p 29-34

Gurbaxani, A., & Packard, R. (2007). Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin, Eye, 21(3):331-2

Nuzzi., R., Arnoffi., P., & Tridico., F. (2018). Best prophylactic strategy in groups at risk of intraoperative floppy iris syndrome, Development: Comparison Between Atropine instillation and Adrenaline Intracameral Injection.,

Skorin, L.Jr. (2010). How to avoid intraoperative floppy iris syndrome,.

Zaman, F., Bach, C., Junaid, I., Athanasios G. P., Jhumur, P., Junaid, M., & Buchholz, N. (2012). The floppy iris syndrome,. 2012, 6(1): 1–7

Downloads

Published

2021-08-16

How to Cite

Trpenoski, N., Veselinovic, A., Cvetanovic, M., & Grekovska Mitrova, M. (2021). MANAGING INTRAOPERATIVE FLOPPY IRIS SYNDROME WITH CANABRAVA PUPIL DILATOR. KNOWLEDGE - International Journal , 47(4), 737–743. Retrieved from http://ikm.mk/ojs/index.php/kij/article/view/4848